This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Cell and gene therapy innovators can now leverage new integrated commercial packaging and distribution services from Thermo Fisher Scientific, designed to seamlessly transition therapies from clinic to commercial launch for patients across the U.S. and Europe.
The Patheon Commercial Packaging Services for Cell and Gene Therapies (CGT) is an end-to-end solution combining the GMP storage, serialization, ultracold and cryogenic packaging, and global distribution that developers need to support their logistics strategies.
“There is a large number of cell and gene therapies reaching commercialization in the next few years that will make a significant impact in patients’ lives,” says Chris Armstrong, president, clinical trial services, Thermo Fisher Scientific. “Our integrated services are specifically designed to meet specialized needs for cell and gene therapies to ensure supply chain integrity from manufacturing through packaging, labeling, and distribution. This will help accelerate the introduction of these important life-saving medicines.”
Highlights of the new services include:
- Regulatory-compliant serialization: Support for the Drug Supply Chain and Security Act (DSCSA) and Falsified Medicines Directive (FMD) designed to ensure that product identity required for allogeneic products is maintained throughout the supply chain.
- Deep expertise in commercial cold-chain and cryogenic storage and global distribution: In-house shipper fleet enables seamless distribution, with experience shipping to over 5,000 clinical sites worldwide in over 39 countries. This enables critical therapies to get to the right patient, at the right time, at the right temperature.
- Patheon Total Transportation Management: White glove courier services for high-value shipments provides complete oversight of supply chain.
- Global infrastructure: Packaging and distribution services available at cryocenters in Frederick, Md., and Weil-am-Rhein, Germany, support commercial launches in the U.S. and E.U.
- Clinical to commercial scalability: Experienced project teams with expertise in clinical trials designed to enable commercial success.
